Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130


Associated clinical characteristics of patients with candidemia among different Candida species.

Chen LY, Kuo SC, Wu HS, Yang SP, Chan YJ, Chen LK, Wang FD.

J Microbiol Immunol Infect. 2013 Dec;46(6):463-8. doi: 10.1016/j.jmii.2012.08.001. Epub 2012 Sep 24.


Clinical significance of time to positivity for yeast in candidemia.

Chen LY, Yang SP, Chen TL, Liao SY, Chen YY, Chan YJ, Chen LK, Wang FD.

J Microbiol Immunol Infect. 2015 Aug;48(4):425-30. doi: 10.1016/j.jmii.2013.11.002. Epub 2013 Dec 30.


Changing epidemiology of candidemia in a medical center in middle Taiwan.

Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY.

J Microbiol Immunol Infect. 2015 Jun;48(3):306-15. doi: 10.1016/j.jmii.2013.08.017. Epub 2013 Oct 8.


Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.

Lin CC, Liu CP, Hsieh FC, Lee CM, Wang WS.

J Microbiol Immunol Infect. 2015 Oct;48(5):552-8. doi: 10.1016/j.jmii.2014.07.007. Epub 2014 Oct 12.


Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Hoffmann-Santos HD, Paula CR, Yamamoto AC, Tadano T, Hahn RC.

Mycopathologia. 2013 Dec;176(5-6):409-15. doi: 10.1007/s11046-013-9705-5. Epub 2013 Oct 11.


Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.

Ma CF, Li FQ, Shi LN, Hu YA, Wang Y, Huang M, Kong QQ.

BMC Infect Dis. 2013 Jul 22;13:337. doi: 10.1186/1471-2334-13-337.


Epidemiology and risk factors for nosocomial Non-Candida albicans candidemia in adult patients at a tertiary care hospital in North China.

Ding X, Yan D, Sun W, Zeng Z, Su R, Su J.

Med Mycol. 2015 Sep;53(7):684-90. doi: 10.1093/mmy/myv060. Epub 2015 Jul 30.


Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.

Dutta A, Palazzi DL.

Pediatr Infect Dis J. 2011 Aug;30(8):664-8. doi: 10.1097/INF.0b013e318213da0f.


Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.

Davis SL, Vazquez JA, McKinnon PS.

Ann Pharmacother. 2007 Apr;41(4):568-73. Epub 2007 Mar 20.


Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá, Colombia.

Cortés JA, Reyes P, Gómez CH, Cuervo SI, Rivas P, Casas CA, Sánchez R.

Braz J Infect Dis. 2014 Nov-Dec;18(6):631-7. doi: 10.1016/j.bjid.2014.06.009. Epub 2014 Sep 1.


Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.

Chen PY, Chuang YC, Wang JT, Sheng WH, Yu CJ, Chu CC, Hsueh PR, Chang SC, Chen YC.

J Microbiol Immunol Infect. 2014 Apr;47(2):95-103. doi: 10.1016/j.jmii.2012.08.025. Epub 2012 Oct 11.


Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.

Dotis J, Prasad PA, Zaoutis T, Roilides E.

Pediatr Infect Dis J. 2012 Jun;31(6):557-60. doi: 10.1097/INF.0b013e31824da7fe.


Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.

Serefhanoglu K, Timurkaynak F, Can F, Cagir U, Arslan H, Ozdemir FN.

J Formos Med Assoc. 2012 Jun;111(6):325-32. doi: 10.1016/j.jfma.2011.03.004. Epub 2012 Mar 23.


Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK.

Das I, Nightingale P, Patel M, Jumaa P.

Int J Infect Dis. 2011 Nov;15(11):e759-63. doi: 10.1016/j.ijid.2011.06.006. Epub 2011 Aug 15.


Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.

Chi HW, Yang YS, Shang ST, Chen KH, Yeh KM, Chang FY, Lin JC.

J Microbiol Immunol Infect. 2011 Oct;44(5):369-75. doi: 10.1016/j.jmii.2010.08.010. Epub 2011 Jan 20.


Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.

Chen CY, Sheng WH, Huang SY, Chou WC, Yao M, Tang JL, Tsay W, Tien HF, Hsueh PR.

J Antimicrob Chemother. 2015 May;70(5):1531-8. doi: 10.1093/jac/dku540. Epub 2015 Jan 3.


Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.

Yapar N, Pullukcu H, Avkan-Oguz V, Sayin-Kutlu S, Ertugrul B, Sacar S, Cetin B, Kaya O.

Med Mycol. 2011 Jan;49(1):26-31. doi: 10.3109/13693786.2010.501344. Epub 2010 Jul 22.


Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.

Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M.

J Clin Microbiol. 2013 Dec;51(12):4167-72. doi: 10.1128/JCM.01998-13. Epub 2013 Oct 9.


Epidemiology and risk factors for non-Candida albicans candidemia in non-neutropenic patients at a Chinese teaching hospital.

Wu JQ, Zhu LP, Ou XT, Xu B, Hu XP, Wang X, Weng XH.

Med Mycol. 2011 Jul;49(5):552-5. doi: 10.3109/13693786.2010.541948. Epub 2010 Dec 9.


Candidemia outcomes not improved with statin use.

Welch ML, Liappis AP, Kan VL.

Med Mycol. 2013 Feb;51(2):219-22. doi: 10.3109/13693786.2012.692490. Epub 2012 Jun 4.

Items per page

Supplemental Content

Write to the Help Desk